Here are six updates from gastroenterology companies and practices from the past week:
GI & Endoscopy
Exact Sciences entered into a deal to acquire Thrive Earlier Detection for up to $2.15 billion.
Exact Sciences posted third-quarter 2020 revenues of $408.5 million, an 86.7 percent year-over-year increase.
The American College of Gastroenterology named the winners of the 2020 SCOPY Awards, which recognize ACG members who excel at colorectal cancer outreach.
After much debate, the U.S. Preventive Services Task Force will issue guidance to lower the colorectal cancer screening age to 45 in response to growing early-onset CRC rates, NBC News reports.
The American College of Gastroenterology's Public Relations Committee recognized 18 posters as newsworthy abstracts during ACG 2020, Oct. 23-28.
COVID-19 patients with gastrointestinal symptoms had higher admission rates to hospitals and intensive care units and higher intubation rates than those without GI symptoms, according to a poster presented at ACG 2020, Oct. 23-28.
Using a noninvasive test to screen for colorectal cancer when a patient turned 45 years old added life years and decreased CRC incidence compared to starting screening when a patient turned 50 years old, according to a poster presented at…
Gastroenterology-focused Dr. Reddy's Laboratories was victim of a cyberattack, Pharmaceutical Technology reported Oct. 23.
Here are the five most-read articles about gastroenterology and endoscopy from Oct. 15-23:
